ALung Technologies recently announced the initiation of patient enrollment in its VENT-AVOID trails with the Minneapolis Heart Institute Foundation. The trial is pivotal in validating the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients who require ventilatory support.
Recent Posts
UPMC Enterprises supporting UPMC response to COVID-19
We are temporarily redirecting our content resources to supporting UPMC’s response to COVID-19.
Read More →
UPMC Enterprises Celebrates International Women’s Day
March 8th is International Women’s Day and many organizations around the world came together to …
Read More →